How early to test for a cancer-causing germline mutation.

How early to test for a cancer-causing germline mutation. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

How early to test for a cancer-causing germline mutation. Abstract Text:

Henry T Lynch,Jane F Lynch,Henry T Lynch,Jane F Lynch,

How early to test for a cancer-causing germline mutation. Publishing Authors By Initials

HT Lynch,JF Lynch,HT Lynch,JF Lynch,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

How early to test for a cancer-causing germline mutation. Journal Published:

PUBLICATION TYPE: Letter

Journal: Cancer genetics and cytogenetics

VOLUME: 180

Page Numbers: 87-8

Journal Abbreviation: Cancer Genet. Cytogenet.

ISSN: 0165-4608

DAY: 1

MONTH: Jan

YEAR: 2008

How early to test for a cancer-causing germline mutation. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7909240

How early to test for a cancer-causing germline mutation. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: How early to test for a cancer-causing germline mutation. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for How early to test for a cancer-causing germline mutation.

AFFILIATION: Department of Preventive Medicine and Public Health, Creighton University School of Medicine, 2500 California Plaza, Omaha, NE 68178.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Cancer Genet Cytogenet

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

How early to test for a cancer-causing germline mutation Related Publications

• Amphibian lipid levels at metamorphosis correlate to post-metamorphic terrestrial survival.
• Brain-derived neurotrophic factor promotes long-term potentiation-related cytoskeletal changes in adult hippocampus.
• Changes in synaptic morphology accompany actin signaling during LTP.
• Chronic hypersensitivity pneumonitis: CT features comparison with pathologic evidence of fibrosis and survival.
• Clinical selection of candidates for mutational testing for cancer susceptibility.
• Current and emerging strategies for the management of sarcoidosis.
• Dietary fish oil deactivates a growth-promoting signaling pathway in hepatoma 7288CTC in Buffalo rats.
• Diindolylquinoxalines: effective indole-based receptors for phosphate anion.
• ENG mutations in MADH4/BMPR1A mutation negative patients with juvenile polyposis.
• Evidence that long-term potentiation occurs within individual hippocampal synapses during learning.
• Familial genes in sporadic disease: common variants of alpha-synuclein gene associate with Parkinson's disease.
• Follicular development during early pregnancy and the estrous cycle of the sow.
• Fyn-mediated phosphorylation of NR2B Tyr-1336 controls calpain-mediated NR2B cleavage in neurons and heterologous systems.
• GAD antibody positive paraneoplastic stiff person syndrome in a patient with renal cell carcinoma.
• Global analysis of alternative splicing during T-cell activation.
• Grade III Gliomas with Imaging Appearances of Glioblastoma should be Managed as Glioblastoma.
• Hereditary cancer syndrome diagnosis: molecular genetic clues and cancer control.
• Large global effective population sizes in Paramecium.
• Nutrient signaling components controlling protein synthesis in striated muscle.
• Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma.
• Pharmacological therapy for Wegener's granulomatosis.
• Presence or absence of lipopolysaccharide O antigens affects type III secretion by Pseudomonas aeruginosa.
• Rapamycin blunts nutrient stimulation of eIF4G, but not PKCepsilon phosphorylation, in skeletal muscle.
• Response to treatment and survival of patients with non-small cell lung cancer undergoing somatic EGFR mutation testing.
• Results from an autonomous underwater vehicle towed hydrophone array experiment in Nantucket Sound.
• Tantalus, a 240MeV Dedicated Source of Synchrotron Radiation, 1968-1986.
• The effect of maternal socio-economic status throughout the lifespan on infant birthweight.
• The relative roles of three DNA repair pathways in preventing Caenorhabditis elegans mutation accumulation.
• Toward a consensus in molecular diagnosis of hereditary nonpolyposis colorectal cancer (Lynch syndrome).
• Who should be sent for genetic testing in hereditary colorectal cancer syndromes?